These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24787287)

  • 21. Molecular imaging: what picture does it paint for future oncology?
    Price P; Jones T
    Drug Discov Today; 2002 Jul; 7(14):741-3. PubMed ID: 12547021
    [No Abstract]   [Full Text] [Related]  

  • 22. Cancer therapy costs influence treatment: a national survey of oncologists.
    Neumann PJ; Palmer JA; Nadler E; Fang C; Ubel P
    Health Aff (Millwood); 2010; 29(1):196-202. PubMed ID: 20048377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer Therapy: Shooting for the Moon.
    Lee J; Blumenthal GM; Hohl RJ; Huang SM
    Clin Pharmacol Ther; 2017 May; 101(5):552-558. PubMed ID: 28418166
    [No Abstract]   [Full Text] [Related]  

  • 24. Value-based reimbursement in oncology.
    Kolodziej M; Hoverman JR
    Am J Manag Care; 2012 May; 18(3 Spec No.):SP124-6. PubMed ID: 22642278
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Translational research--traffic on the bridge.
    Bast RC; Mills GB; Young RC
    Biomed Pharmacother; 2001 Nov; 55(9-10):565-71. PubMed ID: 11769968
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimal cancer care across the spectrum of life and disease.
    Lyman GH; Hauser RS
    Am J Manag Care; 2008 May; 14(5):262-4. PubMed ID: 18471030
    [No Abstract]   [Full Text] [Related]  

  • 28. Linked in: ASCO, NCI tap health information technology to improve cancer prevention, care, and research.
    Printz C
    Cancer; 2012 Dec; 118(23):5721-2. PubMed ID: 23165698
    [No Abstract]   [Full Text] [Related]  

  • 29. Development trends for monoclonal antibody cancer therapeutics.
    Reichert JM; Valge-Archer VE
    Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct-to-consumer advertising in oncology.
    Abel GA; Penson RT; Joffe S; Schapira L; Chabner BA; Lynch TJ
    Oncologist; 2006 Feb; 11(2):217-26. PubMed ID: 16476842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalizing cancer care: American Society of Clinical Oncology presidential address 2009.
    Schilsky RL
    J Clin Oncol; 2009 Aug; 27(23):3725-30. PubMed ID: 19581526
    [No Abstract]   [Full Text] [Related]  

  • 32. [Advances in medical oncology].
    Shi YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer and managed care in the 21st century.
    McGivney WT; Mullen J
    Am J Manag Care; 2005 Dec; 11(17 Suppl):S509-21. PubMed ID: 16336066
    [No Abstract]   [Full Text] [Related]  

  • 34. New NCI drug formulary cuts red tape.
    Weintraub A
    Lab Anim (NY); 2017 Jun; 46(7):285. PubMed ID: 28644447
    [No Abstract]   [Full Text] [Related]  

  • 35. Not at any cost: organizations help patients cope with costs of cancer care.
    Printz C
    Cancer; 2011 Mar; 117(5):879. PubMed ID: 21351079
    [No Abstract]   [Full Text] [Related]  

  • 36. What is the future of oncology? National Cancer Institute initiatives to improve research, development, and implementation in cancer prevention and treatment.
    Hawk E; Viner JL
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S6-9. PubMed ID: 17178278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug shortages delay cancer clinical trials.
    Goozner M
    J Natl Cancer Inst; 2012 Jun; 104(12):891-2. PubMed ID: 22715189
    [No Abstract]   [Full Text] [Related]  

  • 38. The National Cancer Institute and its Director: worthy of our full support.
    Chabner BA
    Oncologist; 2009 Feb; 14(2):108-9. PubMed ID: 19147687
    [No Abstract]   [Full Text] [Related]  

  • 39. Business barriers slowing the pace of cancer immunotherapy research and development.
    Tuma RS
    J Natl Cancer Inst; 2007 Nov; 99(21):1570-3. PubMed ID: 17971521
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of a public-private partnership: translating science to improve cancer care in the community.
    O'Brien DM; Kaluzny AD
    J Healthc Manag; 2014; 59(1):17-29. PubMed ID: 24611422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.